Identificación de los Síntomas Neuropsiquiátricos en Fases Preclínicas y Prodrómicas en Demencias: Desarrollo de un Test de Cribado para el Deterioro Conductual Leve
PDF (English)

Palabras clave

Mild cognitive impairment
Dementia
Neuropsychiatric symptoms
Mild behavioral impairment Deterioro conductual leve
Deterioro cognitivo leve
Demencia
Síntomas neuropsiquiátricos

Cómo citar

Pereira-Abello, C., Cuesta-Izquierdo, M., López-Álvarez, L., & García-Viejo, A. (2024). Identificación de los Síntomas Neuropsiquiátricos en Fases Preclínicas y Prodrómicas en Demencias: Desarrollo de un Test de Cribado para el Deterioro Conductual Leve. Psicothema, 36(1), 91–99. Recuperado a partir de https://reunido.uniovi.es/index.php/PST/article/view/20901

Resumen

Antecedentes: Los síntomas neuropsiquiátricos (SNP) constituyen una dimensión psicopatológica de las enfermedades neurodegenerativas conformada por cambios en la personalidad, trastornos conductuales o alteraciones en funciones básicas como, entre otras, el apetito o el sueño. El objetivo de este estudio es la construcción y validación de un test de cribado para la identificación de estos SNP asociados a patologías neurodegenerativas en etapas preclínicas y prodrómicas y basado en los criterios ISTAART para el Deterioro Conductual Leve (DCoL).

Método: Se empleó una muestra de 206 sujetos mayores de 55 años (117 cognitivamente sanos y 89 con Deterioro Cognitivo Leve) siendo el 69% mujeres, con una media de edad de 77 años (DT = 10,58).

Resultados: La nueva escala desarrollada consta de 19 items y muestra una estructura unidimensional. La fiabilidad fue excelente (α = .94 y Ω = .97) y se observaron evidencias de validez convergente con el test MBI-C con una correlación de .88 y la NPI-Q con .82. Además, muestra una buena sensibilidad de .88 y especificidad de .80.

Conclusiones: La escala desarrollada permite evaluar los SNP en el DCoL mostrando buenas propiedades psicométricas y constituyendo una herramienta muy útil en el diagnóstico precoz de las patologías neurodegenerativas.

PDF (English)

Citas

Aarsland, D., Brønnick, K., Ehrt, U., De Deyn, P. P., Tekin, S., Emre, M., & Cummings, J. L. (2007). Neuropsychiatric symptoms in patients with Parkinson’s disease and dementia: Frequency, profile and associated care giver stress. Journal of Neurology, Neurosurgery, and Psychiatry, 78(1), 36–42. https://doi.org/10.1136/jnnp.2005.083113.

Acosta-Castillo, G. I., Luisa Sosa, A., Orozco, R., & Borges, G. (2012). Síntomas neuropsiquiátricos en adultos mayores con demencia y su relación con la severidad de la enfermedad [Neuropsychiatric symptoms in older adults with dementia and their relationship to disease severity]. Revista de Investigacion Clinica, 64(4), 354–363. https://dialnet.unirioja.es/servlet/articulo?codigo=4065278.

Aguera-Ortiz, L. F., Lopez-Alvarez, J., Del Nido-Varo, L., Soria Garcia-Rosel, E., Perez-Martinez, D. A., & Ismail, Z. (2017). Deterioro comportamental leve como antecedente de la demencia: presentacion de los criterios diagnosticos y de la version española de la escala MBI-C para su valoración [Mild behavioural impairment as an antecedent of dementia: presentation of the diagnostic criteria and the Spanish version of the MBI-C scale for its evaluation]. Revista de Neurologia, 65(7), 327–334. https://doi.org/10.33588/rn.6507.2017170

Ballard, C., Day, S., Sharp, S., Wing, G., & Sorensen, S. (2008). Neuropsychiatric symptoms in dementia: importance and treatment considerations. International Review of Psychiatry, 20(4), 396–404. https://doi.org/10.1080/09540260802099968.

Ballard, C., Aarsland, D., Francis, P., & Corbett, A. (2013). Neuropsychiatric symptoms in patients with dementias associated with cortical Lewy bodies: Pathophysiology, clinical features, and pharmacological management. Drugs & Aging, 30(8), 603–611. https://doi.org/10.1007/s40266-013-0092-x.

Banks, S. J., Raman, R., He, F., Salmon, D. P., Ferris, S., Aisen, P., & Cummings, J. (2014). The Alzheimer’s disease cooperative study prevention instrument project: Longitudinal outcome of behavioral measures as predictors of cognitive decline. Dementia and Geriatric Cognitive Disorders Extra, 4(3), 509–516. https://doi.org/10.1159/000357775.

Barua, A., Ghosh, M. K., Kar, N., & Basilio, M. A. (2011). Prevalence of depressive disorders in the elderly. Annals of Saudi Medicine, 31(6), 620– 624. https://doi.org/10.4103/0256-4947.87100.

Blesa, R., Pujol, M., Aguilar, M., Santacruz, P., Bertran-Serra, I., Hernández, G., Sol, J. M., Peña-Casanova, J., & NORMACODEM Group. NORMAlisation of Cognitive and Functional Instruments for DEMentia (2001). Clinical validity of the ‘mini-mental state’ for Spanish speaking communities. Neuropsychologia, 39(11), 1150–1157. https://doi.org/10.1016/s0028-3932(01)00055-0.

Boada, M., Cejudo, J. C., Tàrraga, L., López, O. L., & Kaufer, D. (2002). Neuropsychiatric Inventory Questionnaire (NPI-Q): validación española de una forma abreviada del Neuropsychiatric Inventory (NPI)* [Neuropsychiatric inventory questionnaire (NPI-Q): Spanish validation of an abridged form of the Neuropsychiatric Inventory (NPI)]. Neurologia, 17(6), 317–323. https://pesquisa.bvsalud.org/portal/resource/pt/ibc-16385.

Bryant, C., Jackson, H., & Ames, D. (2008). The prevalence of anxiety in older adults: methodological issues and a review of the literature. Journal of Affective Disorders, 109(3), 233–250. https://doi.org/10.1016/j.jad.2007.11.008.

Burhanullah, M. H., Tschanz, J. T., Peters, M. E., Leoutsakos, J. M., Matyi, J., Lyketsos, C. G., Nowrangi, M. A., & Rosenberg, P. B. (2020). Neuropsychiatric symptoms as risk factors for cognitive decline in clinically normal older adults: The Cache County Study. The American Journal of Geriatric Psychiatry, 28(1), 64–71. https://doi.org/10.1016/j.jagp.2019.03.023.

Calderón Garrido, C., Navarro González, D., Lorenzo Seva, U., & Ferrando Piera, P. J. (2019). Multidimensional or essentially unidimensional? A multi-faceted factor-analytic approach for assessing the dimensionality of tests and items. Psicothema, 31(4), 450–457. https://doi.org/10.7334/psicothema2019.153.

Cerejeira, J., Lagarto, L., & Mukaetova-Ladinska, E. B. (2012). Behavioral and psychological symptoms of dementia. Frontiers in Neurology, 3, Article 73. https://doi.org/10.3389/fneur.2012.00073.

Chen, T. H., Yeh, Y. C., Huang, M. F., Chen, H. M., Lee, J. I., & Chen, C. S. (2022). Validation and comparison of the informant-rated and selfrated versions of the Mild Behavioral Impairment Checklist. Journal of Alzheimer’s Disease: JAD, 90(3), 1203–1213. https://doi.org/10.3233/JAD-220006.

Cieslak, A., Smith, E. E., Lysack, J., & Ismail, Z. (2018). Case series of mild behavioral impairment: Toward an understanding of the early stages of neurodegenerative diseases affecting behavior and cognition. International Psychogeriatrics, 30(2), 273–280. https://doi.org/10.1017/S1041610217001855.

Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A., & Gornbein, J. (1994). The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia. Neurology, 44(12), 2308–2314. https://doi.org/10.1212/wnl.44.12.2308.

Cummings J. (2021). The role of neuropsychiatric symptoms in research diagnostic criteria for neurodegenerative diseases. The American Journal of Geriatric Psychiatry, 29(4), 375–383. https://doi.org/10.1016/j.jagp.2020.07.011.

Donovan, N. J., Amariglio, R. E., Zoller, A. S., Rudel, R. K., Gomez-Isla, T., Blacker, D., Hyman, B. T., Locascio, J. J., Johnson, K. A., Sperling, R. A., Marshall, G. A., & Rentz, D. M. (2014). Subjective cognitive concerns and neuropsychiatric predictors of progression to the early clinical stages of Alzheimer disease. The American Journal of Geriatric Psychiatry, 22(12), 1642–1651. https://doi.org/10.1016/j.jagp.2014.02.007.

Dubois, B., Slachevsky, A., Litvan, I., & Pillon, B. (2000). The FAB: A Frontal Assessment Battery at bedside. Neurology, 55(11), 1621–1626. https://doi.org/10.1212/wnl.55.11.1621.

Feldman, H., Scheltens, P., Scarpini, E., Hermann, N., Mesenbrink, P., Mancione, L., Tekin, S., Lane, R., & Ferris, S. (2004). Behavioral symptoms in mild cognitive impairment. Neurology, 62(7), 1199–1201. https://doi.org/10.1212/01.wnl.0000118301.92105.ee.

Ferrando, P. J., & Lorenzo-Seva, U. (2017). Program FACTOR at 10: Origins, development and future directions. Psicothema, 29(2), 236–240. https://doi.org/10.7334/psicothema2016.304.

Ferrando, P. J., Lorenzo-Seva, U., Hernández-Dorado, A., & Muñiz, J. (2022). Decalogue for the factor analysis of test items. Psicothema, 34(1), 1-7. https://doi.org/10.7334/psicothema2021.456

Ferrín, M. T., González, L.F., & Meijide-Míguez, H. (2011). Escalas de valoración funcional en el anciano [Functional Assesment Scales in the Elderly]. Galicia Clínica, 72(1), 11-16. https://dialnet.unirioja.es/descarga/articulo/4098178.pdf.

Fischer, C. E., Ismail, Z., & Schweizer, T. A. (2012a). Impact of neuropsychiatric symptoms on caregiver burden in patients with Alzheimer’s disease. Neurodegenerative Disease Management, 2(3), 269–277. https://doi.org/10.2217/nmt.12.19.

Fischer, C. E., Ismail, Z., & Schweizer, T. A. (2012b). Delusions increase functional impairment in Alzheimer’s disease. Dementia and Geriatric Cognitive Disorders, 33(6), 393–399. https://doi.org/10.1159/000339954.

Fiske, A., Wetherell, J. L., & Gatz, M. (2009). Depression in older adults. Annual Review of Clinical Psychology, 5, 363–389. https://doi.org/10.1146/annurev.clinpsy.032408.153621.

Gómez-Benito, J., Hidalgo, M. D., & Zumbo, B. D. (2013). Effectiveness of combining statistical tests and effect sizes when using logistic discriminant function regression to detect differential item functioning for polytomous items. Educational and Psychological Measurement, 73(5), 875- 897. https://doi.org/10.1177/0013164413492419.

Ismail, Z., Agüera-Ortiz, L., Brodaty, H., Cieslak, A., Cummings, J., Fischer, C. E., Gauthier, S., Geda, Y. E., Herrmann, N., Kanji, J., Lanctôt, K. L., Miller, D. S., Mortby, M. E., Onyike, C. U., Rosenberg, P. B., Smith, E. E., Smith, G. S., Sultzer, D. L., Lyketsos, C., & NPS Professional Interest Area of the International Society of to Advance Alzheimer’s Research and Treatment (NPS-PIA of ISTAART) (2017). The Mild Behavioral Impairment Checklist (MBI-C): A rating scale for neuropsychiatric symptoms in predementia populations. Journal of Alzheimer’s Disease, 56(3), 929–938. https://doi.org/10.3233/JAD-160979.

Ismail, Z., Smith, E. E., Geda, Y., Sultzer, D., Brodaty, H., Smith, G., Agüera-Ortiz, L., Sweet, R., Miller, D., Lyketsos, C. G., & ISTAART Neuropsychiatric Symptoms Professional Interest Area (2016). Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairment. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 12(2), 195–202. https://doi.org/10.1016/j.jalz.2015.05.017.

Karttunen, K., Karppi, P., Hiltunen, A., Vanhanen, M., Välimäki, T., Martikainen, J., Valtonen, H., Sivenius, J., Soininen, H., Hartikainen, S., Suhonen, J., Pirttilä, T., & ALSOVA study group (2011). Neuropsychiatric symptoms and quality of life in patients with very mild and mild Alzheimer’s disease. International Journal of Geriatric Psychiatry, 26(5), 473–482. https://doi.org/10.1002/gps.2550.

Köhler, S., Allardyce, J., Verhey, F. R., McKeith, I. G., Matthews, F., Brayne, C., Savva, G. M., & Medical Research Council Cognitive Function and Ageing Study (2013). Cognitive decline and dementia risk in older adults with psychotic symptoms: a prospective cohort study. The American Journal of Geriatric Psychiatry: Official Journal of the American Association for Geriatric Psychiatry, 21(2), 119–128. https://doi.org/10.1016/j.jagp.2012.10.010.

Lanctôt, K. L., Amatniek, J., Ancoli-Israel, S., Arnold, S. E., Ballard, C., Cohen-Mansfield, J., Ismail, Z., Lyketsos, C., Miller, D. S., Musiek, E., Osorio, R. S., Rosenberg, P. B., Satlin, A., Steffens, D., Tariot, P., Bain, L. J., Carrillo, M. C., Hendrix, J. A., Jurgens, H., & Boot, B. (2017). Neuropsychiatric signs and symptoms of Alzheimer’s disease: New treatment paradigms. Alzheimer’s & Dementia, 3(3), 440–449. https://doi.org/10.1016/j.trci.2017.07.001.

Landau, S. M., Harvey, D., Madison, C. M., Reiman, E. M., Foster, N. L., Aisen, P. S., Petersen, R. C., Shaw, L. M., Trojanowski, J. Q., Jack, C. R., Jr, Weiner, M. W., Jagust, W. J., & Alzheimer’s Disease Neuroimaging Initiative (2010). Comparing predictors of conversion and decline in mild cognitive impairment. Neurology, 75(3), 230–238. https://doi.org/10.1212/WNL.0b013e3181e8e8b8.

Lawton, M. P., & Brody, E. M. (1969). Assessment of older people: Selfmaintaining and instrumental activities of daily living. The Gerontologist, 9(3), 179–186. https://doi.org/10.1093/geront/9.3_1.179.

Leoutsakos, J. M., Forrester, S. N., Lyketsos, C. G., & Smith, G. S. (2015). Latent Classes of Neuropsychiatric Symptoms in NACC controls and conversión to mild cognitive impairment or dementia. Journal of Alzheimer’s Disease, 48(2), 483–493. https://doi.org/10.3233/JAD-150421.

Lobo, A., Saz, P., Marcos, G., Día, J. L., de la Cámara, C., Ventura, T., Morales Asín, F., Fernando Pascual, L., Montañés, J. A., & Aznar, S. (1999). Revalidación y normalización del Mini-Examen Cognoscitivo (primera versión en castellano del Mini-Mental Status Examination) en la población general geriátrica [Revalidation and standardization of the cognition miniexam (first Spanish version of the Mini-Mental Status Examination) in the general geriatric population]. Medicina Clinica, 112(20), 767–774. https://www.elsevier.es/en/linksolver/ft/ivp/0025-7753/112/767.

Lorenzo-Seva, U., & Ferrando, P. J. (2013). FACTOR 9.2: A comprehensive program for fitting exploratory and semiconfirmatory factor analysis and IRT models. Applied Psychological Measurement, 37(6), 497–498. https://doi.org/10.1177/0146621613487794.

Lorenzo-Seva, U., & Ferrando, P. J. (2021). MSA: The forgotten index for identifying inappropriate items before computing exploratory item factor analysis. Methodology, 17(4), 296-306. https://doi.org/10.5964/meth.7185

Mallo, S. C., Ismail, Z., Pereiro, A. X., Facal, D., Lojo-Seoane, C., Campos-Magdaleno, M., & Juncos-Rabadán, O. (2018). Assessing mild behavioral impairment with the Mild Behavioral Impairment-Checklist in people with mild cognitive impairment. Journal of Alzheimer’s Disease, 66(1), 83–95.https://doi.org/10.3233/JAD-180131.

Mallo, S. C., Ismail, Z., Pereiro, A. X., Facal, D., Lojo-Seoane, C., Campos-Magdaleno, M., & Juncos-Rabadán, O. (2019). Assessing mild behavioral impairment with the mild behavioral impairment checklist in people with subjective cognitive decline. International Psychogeriatrics, 31(2), 231–239. https://doi.org/10.1017/S1041610218000698.

Masters, M. C., Morris, J. C., & Roe, C. M. (2015). “Noncognitive” symptoms of early Alzheimer disease: A longitudinal analysis. Neurology, 84(6), 617–622. https://doi.org/10.1212/WNL.0000000000001238.

Meulen, E. F., Schmand, B., van Campen, J. P., de Koning, S. J., Ponds, R. W., Scheltens, P., & Verhey, F. R. (2004). The Seven Minute Screen: A neurocognitive screening test highly sensitive to various types of dementia. Journal of Neurology, Neurosurgery, and Psychiatry, 75(5), 700–705. https://doi.org/10.1136/jnnp.2003.021055.

Nowrangi, M. A., Lyketsos, C. G., & Rosenberg, P. B. (2015). Principles and management of neuropsychiatric symptoms in Alzheimer’s dementia. Alzheimer’s Research & Therapy, 7(1), Article 12. https://doi.org/10.1186/s13195-015-0096-3.

Ortega-Orcos, R., Salinero-Fort, M. A., Khajoui, A. K, Aparicio, S.V, & de Dios del Valle, R. (2007). Validación de la versión española de 5 y 15 ítems de la Escala de Depresión Geriátrica en personas mayores en Atención Primaria [Validation of 5 and 15 items Spanish versión of the geriatric depression scale in elderly subjects in primary health care setting]. Revista Clinica Española, 207(11), 559–562. https://doi.org/10.1157/13111585.

Pink, A., Stokin, G. B., Bartley, M. M., Roberts, R. O., Sochor, O., Machulda, M. M., Krell-Roesch, J., Knopman, D. S., Acosta, J. I., Christianson, T. J., Pankratz, V. S., Mielke, M. M., Petersen, R. C., & Geda, Y. E. (2015). Neuropsychiatric symptoms, APOE ε4, and the risk of incident dementia: a population-based study. Neurology, 84(9), 935–943. https://doi.org/10.1212/WNL.0000000000001307.

Rosenberg, P. B., Mielke, M. M., Appleby, B. S., Oh, E. S., Geda, Y. E., & Lyketsos, C. G. (2013). The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease. The American journal of geriatric psychiatry: official journal of the American Association for Geriatric Psychiatry, 21(7), 685–695. https://doi.org/10.1016/j.jagp.2013.01.006.

Sheikh, F., Ismail, Z., Mortby, M. E., Barber, P., Cieslak, A., Fischer, K., Granger, R., Hogan, D. B., Mackie, A., Maxwell, C. J., Menon, B., Mueller, P., Patry, D., Pearson, D., Quickfall, J., Sajobi, T., Tse, E., Wang, M., Smith, E. E., & PROMPT registry investigators (2018). Prevalence of mild behavioral impairment in mild cognitive impairment and subjective cognitive decline, and its association with caregiver burden. International Psychogeriatrics, 30(2), 233–244. https://doi.org/10.1017/S104161021700151X.

Simonetti, A., Pais, C., Jones, M., Cipriani, M. C., Janiri, D., Monti, L., Landi, F., Bernabei, R., Liperoti, R., & Sani, G. (2020). Neuropsychiatric symptoms in elderly with dementia during COVID-19 pandemic: Definition, treatment, and cuture directions. Frontiers in Psychiatry, 11, Article 579842. https://doi.org/10.3389/fpsyt.2020.579842.

Steinberg, M., Shao, H., Zandi, P., Lyketsos, C. G., Welsh-Bohmer, K. A., Norton, M. C., Breitner, J. C., Steffens, D. C., Tschanz, J. T., & Cache County Investigators (2008). Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: The Cache County Study. International Journal of Geriatric Psychiatry, 23(2), 170–177. https://doi.org/10.1002/gps.1858.

Taragano, F. E., Allegri, R. F., Heisecke, S. L., Martelli, M. I., Feldman, M. L., Sánchez, V., García, V. A., Tufro, G., Castro, D. M., Leguizamón, P. P., Guelar, V., Ruotolo, E., Zegarra, C., & Dillon, C. (2018). Risk of conversion to dementia in a mild behavioral impairment group compared to a psychiatric group and to a mild cognitive impairment group. Journal of Alzheimer’s Disease, 62(1), 227–238. https://doi.org/10.3233/JAD-170632.

Teng, E., Lu, P. H., & Cummings, J. L. (2007). Neuropsychiatric symptoms are associated with progression from mild cognitive impairment to Alzheimer’s disease. Dementia and Geriatric Cognitive Disorders, 24(4), 253–259. https://doi.org/10.1159/000107100.

Wise, E. A., Rosenberg, P. B., Lyketsos, C. G., & Leoutsakos, J. M. (2019). Time course of neuropsychiatric symptoms and cognitive diagnosis in national Alzheimer’s coordinating centers volunteers. Alzheimer’s & Dementia, 11, 333–339. https://doi.org/10.1016/j.dadm.2019.02.006.

Woolley, J. D., Khan, B. K., Murthy, N. K., Miller, B. L., & Rankin, K. P. (2011). The diagnostic challenge of psychiatric symptoms in neurodegenerative disease: Rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease. The Journal of Clinical Psychiatry, 72(2), 126–133. https://doi.org/10.4088/JCP.10m06382oli.

Yesavage, J. A., Brink, T. L., Rose, T. L., Lum, O., Huang, V., Adey, M., & Leirer, V. O. (1982). Development and validation of a geriatric depression screening scale: A preliminary report. Journal of Psychiatric Research, 17(1), 37–49. https://doi.org/10.1016/0022-3956(82)90033-4.

Zubenko, G. S., Moossy, J., Martinez, A. J., Rao, G., Claassen, D., Rosen, J., & Kopp, U. (1991). Neuropathologic and neurochemical correlates of psychosis in primary dementia. Archives of Neurology, 48(6), 619–624. https://doi.org/10.1001/archneur.1991.00530180075020.